SUMMARY Increased marrow cellularity is well recognised in polycythaemia rubra vera (PRV), but its value in the differential diagnosis of polycythaemia is not always appreciated. In 28 patients who had marrow aspiration performed on account of a raised haemoglobin concentration or red blood cell count (RBC), marrow cellularity was assessed subjectively and also measured; a comparison was made with the white blood cell count (WBC), platelet count, presence of splenomegaly and plasma volume (PV). Marrow cellularity, particularly when measured was shown to be the most reliable method of making a positive diagnosis of polycythaemia vera; cellularity of greater than 75% makes it unnecessary to perform other investigations to exclude secondary erythrocytosis.
The diagnosis of polycythaemia rubra vera (PRV) classically depends on the triad of ruddy cyanosis, splenomegaly and increased red cell mass. ' However, some 20-30% of patients lack the clinical features and the diagnosis is then based on the exclusion of causes for secondary erythrocytosis. Increased marrow cellularity has long been recognised as a feature of PRV and two studies some ten years ago emphasised the value of a subjective assessment of marrow cellularity on either sections of bone marrow particles or trephine sections in the diagnosis of PRV.23 However, the diagnostic value of increased marrow cellularity is not always accepted, perhaps because cellularity as assessed from marrow smears is not of discriminating value between PRV and secondary erythrocytosis. Thus the polycythaemia vera study group did not include marrow cellularity in their diagnostic criteria for PRV. 4 In this study marrow cellularity was estimated in bone marrow specimens, taken in the course of investigation of a raised haemoglobin concentration or red blood cell count; the diagnostic value of marrow cellularity was compared with other criteria in common use.
Patients and methods
The 28 patients in this study consisted investigation of a raised haemoglobin concentration or RBC in the peripheral blood. Two additional patients in this period were excluded due to inadequate marrow material available for examination. No patients had received radioactive phosphorus or cytotoxic therapy prior to marrow examination.
MARROW SECTIONS
Sections were prepared from aspirated material; haematoxylin and eosin (HE) and Perls' Prussian blue stains were performed. Marrow cellularity was assessed on the HE sections using a random point grid inserted into the microscope eyepiece; 200 points were assessed by each of two observers. Points overlying haemopoietic tissue were scored and expressed as a percentage of those overlying haemopoietic tissue and fat spaces. Lymphoid tissue was not included. When the two observers disagreed by more than 7%, the slides were reassessed, otherwise the marrow cellularity was expressed as the average of the two scores. Marrow cellularity in all instances was assessed without knowledge of the patient's diagnosis or identity.
Haemoglobin, red cell and white cell counts and absolute values were measured with a Coulter Model S. Platelet counts were estimated by a semiautomated method using a Coulter ZF after the method of Bull et al. 5 Plasma volumes were available in all instances; and measured using a radioisotope dilution technique with 131I albumin. Directly measured red cell volumes were not always available but when carried out were estimated using 5'Cr red cell labelling.
Splenic scans were performed using technetium Tc99M
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Results
The mean cellularity of the marrows for the three groups of patients is shown in the Figure. Patients Table 1 shows the peripheral blood values, qualitative with PRV are clearly distinguishable from the other assessment of the marrow sections, marrow groups (p > 0 001) but those with secondary cellularity, and the final diagnosis. Fourteen patients erythrocytosis and reduced plasma volumes are not had PRV, six secondary erythrocytosis and eight significantly different. reduced plasma volumes with no increase in red cell
Of the 14 patients with PRV, 13 had cellularity mass. All patients have now been followed for at least greater than 75% while none of the others had as three years and in no instance has the "final cellular a marrow. The patient (No 20) with the diagnosis" had to be changed. In 12/14 patients with cerebellar haemangioblastoma had 70 5% marrow PRV a confident accurate diagnosis was made cellularity. qualitatively though in two instances some doubt
The haematological features of the three groups existed. Of the other groups the "secondary" nature are summarised in Table 2 . Depletion of iron stores of the disorder was diagnosed in 13/14 instances (with was present in almost all patients with PRV, probably some reserve in three instances by one observer). The accounting for the lower MCV. However depletion one exception, thought to be most likely, though not was also found in the other groups. definitely PRV by both observers, was initially As expected, WBC and platelet count are higher in diagnosed as having PRV but a few months later PRV and clinical splenomegaly is confined to this developed a cerebellar haemangioblastoma.
disorder. Splenic scans were not performed in all Plasma volume estimations were not of value in the diagnosis of PRV. In this disorder the mean PV was 40-0 ml/kg compared with 35-9 ml/kg in secondary erythrocytosis and 32 4 ml/kg in those with reduced plasma volume. In the seven patients with PRV and * splenomegaly the mean plasma volume was 40 6 + 4 7 ml/kg (mean ± SD) compared with 39 4 + 5-0 ml/kg in the seven patients without clinically enlarged spleens.
In Table 3 the comparative value of the diagnostic features is assessed. WBC, platelets and presence of splenomegaly are of discriminating value but even taken together they are less discriminatory than marrow cellularity. All four of the PRV patients who lacked a high WBC, platelet count or splenomegaly, had marrow cellularity greater than 75% (patient Nos 3,4,12,13).
Discussion
Although in general bone marrow trephine is a preferable technique in the myeloproliferative Of; disorders, the cellularity of normal iliac marrow has been shown to decrease in the elderly.6 Thus sternal uips ofpatients, showing a vith PRVfrom the other marrow aspirate may be more reliable in the assessment of cellularity and this study has confirmed Marrow cellularity in the diagnosis ofpolycythaemia earlier work23 showing that sections prepared from bone marrow aspiration gives valuable information in the diagnosis of polycythaemia. Only one out of 14 patients with PRV had cellularity less than 75% while none of the patients in the other groups had such a cellular marrow. In the majority of instances a subjective assessment of cellularity was adequate, but in some patients a quantitative measurement, which could be performed in less than 10 minutes, allowed greater precision.
Of the positive features which are generally considered to have value in diagnosing PRV-the WBC, platelet count, splenomegaly and marrow cellularity, marrow cellularity has been demonstrated to be clearly supeirior to the others. Even in combination, the other features are not as discriminatory as marrow cellularity and it is noteworthy that four patients with PRV had none of the other features.
It is possible on occasion for PRV to present with an increased red cell mass but no positive feature including increased marrow cellularity to point to the diagnosis; no patient in the present series fell into this category. In this situation, extensive investigation to exclude secondary causes is usually required. However, with this proviso, in the majority of 
